301-519-2100 • FAX 301-519-2892 • 207 PERRY PARKWAY GAITHERSBURG, MD 20877
SEARCH
Congenital Amegakaryocytic Thrombocytopenia
MPL (myeloproliferative leukemia virus oncogene)
Disclaimer:
This test is not suitable for patients with myeloproliferative disease or other acquired adult disorders. It is intended for diagnosis of congenital amegakaryocytic thrombocytopenia. It also can be used for certain inherited forms of thrombocytosis.
The MPL gene, a historical name, encodes TPOR, the thrombopoietin receptor. Mutations in MPL/TPOR cause congenital unresponsiveness to thrombopoietin (TPO) leading to amegakaryocytic thrombocytopenia. In early studies of 31 published patients with CAMT, 30 had two mutated MPL genes while 1 had no observed mutations. In the test performed at GeneDx, each of the 12 MPL exons is screened by bi-directional sequence analysis using DNA isolated from 1-5 mL peripheral blood or one pair of GeneDx buccal (cheek) brushes. Test sensitivity for the type of mutations expected in this disorder is estimated at over 95%. This form of thrombocytopenia is not associated with absent radii or TAR syndrome. For more details see the linked Information Sheet below.
Information Sheet, including prices and CPT codes
Consent Document
Genetic Test Sample Submission Form (Test Requisition Form) including Payment Options
Congenital amegakaryocytic thrombocytopenia, Thrombocytopenia, Bone Marrow Failure, Marrow cMPL, c-MPL, platelet, aplastic anemia
© 2000 - 2010 GeneDx. All rights reserved.
